MedPath

To study the changes in the tongue and upper respiratory tract in patients who are to sleep using the two different drugs

Not Applicable
Conditions
Health Condition 1: null- Patients undergoing sleep endoscopy for obstructive sleep apnea
Registration Number
CTRI/2017/05/008530
Lead Sponsor
Postgraduate Institute of medical education and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

All ASA I and II patients between the age of 18-60 years scheduled to undergo Drug induced sleep endoscopy

Exclusion Criteria

•patients who have undergone previous upper airway surgery for OSA

•severe co morbidity (ASA 3 or more)

•allergy to dexmedetomidine and propofol

•gross mandibular or maxillary deformity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of airway collapsibility at different levels of sedationTimepoint: compare the degree of airway collapsibility with Propofol and Dexmedetomidine at different levels of sedation by BIS during Drug Induced Sleep Endoscopy
Secondary Outcome Measures
NameTimeMethod
1.cardiopulmonary effects <br/ ><br>2. Time to achieve sufficient sedation <br/ ><br>3. Haemodynamic response to drugs <br/ ><br>4.Side effects and to identify the contributing factors for airway collapsibility.Timepoint: 5 minutes,10 minutes, 15 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, 60 minutes.
© Copyright 2025. All Rights Reserved by MedPath